CooperCompanies to Participate in the Morgan Stanley Virtual Global Healthcare Conference
CooperCompanies (NYSE: COO) will participate in the Morgan Stanley Virtual 18th Annual Global Healthcare Conference on September 16, 2020, with Senior VP and CFO Brian Andrews leading the presentation starting at 2:45 pm ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
CooperCompanies (NYSE: COO) will participate in the Morgan Stanley Virtual 18th Annual Global Healthcare Conference on September 16, 2020, with Senior VP and CFO Brian Andrews leading the presentation starting at 2:45 pm ET. Interested investors can access the session via a webcast on Cooper's Investor Relations website.
Cooper operates globally with two main units: CooperVision, focusing on vision care products, and CooperSurgical, dedicated to women's health and fertility solutions. The company has over 12,000 employees and products available in more than 100 countries.
Details
News Market Reaction – COO
The recorded move for COO in the trading session of this news was -2.04%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN RAMON, Calif., Aug. 19, 2020 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), will participate in the Morgan Stanley Virtual 18th Annual Global Healthcare Conference, on September 16, 2020. Brian Andrews, Senior Vice President, Chief Financial Officer & Treasurer, will represent the Company in a session scheduled to begin at 2:45 pm ET.
A webcast of the session will be available on the Investor Relations section of the Company's website at http://investor.coopercos.com.
About CooperCompanies
CooperCompanies ("Cooper") is a global medical device company publicly traded on the NYSE (NYSE:COO). Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics. Headquartered in San Ramon, Calif., Cooper has a workforce of more than 12,000 with products sold in over 100 countries. For more information, please visit www.coopercos.com.
Contact:
Kim Duncan
Vice President, Investor Relations and Risk Management
925-460-3663
ir@cooperco.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.